Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OTCMKTS:ICOTF

iCo Therapeutics (ICOTF) Stock Price, News & Analysis

iCo Therapeutics logo

About iCo Therapeutics Stock (OTCMKTS:ICOTF)

Advanced Chart

Key Stats

Today's Range
$0.51
$0.56
50-Day Range
$0.30
$0.42
52-Week Range
$0.80
$1.82
Volume
90,488 shs
Average Volume
4,760 shs
Market Capitalization
$4.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.

Receive ICOTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ICOTF Stock News Headlines

MSCLF Satellos Bioscience Inc.
ICO Group Ltd.
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?
Satellos Bioscience Inc (MSCL)
See More Headlines

Company Calendar

Today
5/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ICOTF
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,110,000.00
Pretax Margin
-4,148.78%

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-7.98

Miscellaneous

Free Float
N/A
Market Cap
$5.06 million
Optionable
Not Optionable
Beta
2.03
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:ICOTF) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners